More than one billion people worldwide are living with obesity, which increases their risk of major health complications, including T2D, high blood pressure, heart disease, stroke, metabolic syndrome, fatty liver diseases, some cancers, kidney disease, breathing problems, and sleep apnea
The main focus should be on managing overlapping digestive side effects and maintaining hydration
Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide
By slowing the movement of food through the digestive system, semaglutide and tirzepatide extend feelings of fullness, helping patients naturally reduce their calorie intake